51. Dose tapering to withdrawal stage and long‐term efficacy and safety of hetrombopag for the treatment of immune thrombocytopenia: Results from an open‐label extension study. (15th December 2021) Authors: Mei, Heng; Liu, Xiaofan; Li, Yan; Zhou, Hu; Feng, Ying; Gao, Guangxun; Cheng, Peng; Huang, Ruibin; Yang, Linhua; Hu, Jianda; Hou, Ming; Yao, Yazhou; Liu, Li; Wang, Yi; Wu, Depei; Zhang, Liansheng; Zheng, Changcheng; Shen, Xuliang; Hu, Qi; Liu, Jing Journal: Journal of thrombosis and haemostasis Issue: Volume 20:Number 3(2022) Page Start: 716 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
52. Dual epigenetic agents plus rituximab–gemcitabine–oxaliplatin as salvage treatment in relapsed/refractory diffuse large B‐cell lymphoma patients failure of salvage chemotherapy. Issue 5 (12th August 2022) Authors: Qu, Changju; Ping, Nana; Kong, Danqing; Liu, Aining; Liu, Hailing; Xu, Ting; Xia, Fan; Wu, Depei; Jin, Zhengming Journal: Hematological oncology Issue: Volume 40:Issue 5(2022) Page Start: 914 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
53. Dynamic mRNA expression of donor-derived activating KIR genes and their significant effects on clinical outcome after haematopoietic stem cell transplantation. (6th July 2021) Authors: Li, Ying; Wang, Tian; Hu, Xing; Zhang, Huanhuan; Bao, Xiaojing; Wu, Depei; He, Jun Journal: Clinical and experimental immunology Issue: Volume 205:Number 3(2021) Page Start: 417 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
54. Dynamic mRNA expression of donor‐derived activating KIR genes and their significant effects on clinical outcome after haematopoietic stem cell transplantation. (6th July 2021) Authors: Li, Ying; Wang, Tian; Hu, Xing; Zhang, Huanhuan; Bao, Xiaojing; Wu, Depei; He, Jun Journal: Clinical and experimental immunology Issue: Volume 205:Number 3(2021) Page Start: 417 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
55. E3 ubiquitin ligase MID1 ubiquitinates and degrades type‐I interferon receptor 2. Issue 3 (23rd July 2022) Authors: Chen, Xiangjie; Zhao, Qian; Xu, Ying; Wu, Qiuyu; Zhang, Renxia; Du, Qian; Miao, Ying; Zuo, Yibo; Zhang, Hong‐Guang; Huang, Fan; Ren, Tengfei; He, Jiuyi; Qiao, Caixia; Li, Yue; Li, Shifeng; Xu, Yang; Wu, Depei; Yu, Zhengyuan; Lv, Haitao; Wang, Jun Journal: Immunology Issue: Volume 167:Issue 3(2022) Page Start: 398 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
56. Efficacy and safety of prophylaxis with BAY 81‐8973 in Chinese patients with severe haemophilia A enrolled in the LEOPOLD II trial. Issue 3 (17th April 2019) Authors: Yang, Renchi; Sun, Jing; Zhao, Yongqiang; Wang, Xuefeng; Wu, Depei; Tseneklidou‐Stoeter, Despina; Wu, Junde; Church, Nikki Journal: Haemophilia Issue: Volume 25:Issue 3(2019) Page Start: e153 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
57. Efficacy and toxicity of SEAM (semustine, etoposide, cytarabine, and melphalan) conditioning regimen followed by autologous stem cell transplantation in lymphoma. Issue 1 (31st December 2022) Authors: Zhang, Lihong; Yang, Haifei; Qian, Chongsheng; Zhou, Jihao; Zhu, Qian; Jiang, Yibin; Liu, Shuo; Chen, Xiaochen; Xu, Ting; Qu, Changju; Li, Caixia; Jin, Zhengming; Chu, Jianhong; Zhang, Xinyou; Wu, Depei; Huang, Haiwen Journal: Hematology Issue: Volume 27:Issue 1(2022) Page Start: 404 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
58. Efficacy of cytarabine, aclarubicin and granulocyte colony-stimulating factor (CAG) regimen compared to FLAG regimen for adult patients with relapsed/refractory Philadelphia chromosome-negative acute lymphoblastic leukemia. Issue 11 (November 2015) Authors: Li, Xiaoli; Liu, Limin; Zhang, Yanming; Qu, Qi; Yao, Yao; Wang, Tong; Jiao, Wenjing; Wu, Depei Journal: Leukemia research Issue: Volume 39:Issue 11(2015:Nov.) Page Start: 1201 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
59. Efficacy of low-dose cytarabine and aclarubicin in combination with granulocyte colony-stimulating factor (CAG regimen) compared to Hyper-CVAD regimen as salvage chemotherapy in relapsed/refractory Philadelphia chromosome-negative acute lymphoblastic leukemia. Issue 3 (March 2015) Authors: Liu, Limin; Jiao, Wenjing; Zhang, Yanming; Qu, Qi; Li, Xiaoli; Wu, Depei Journal: Leukemia research Issue: Volume 39:Issue 3(2015:Mar.) Page Start: 323 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
60. Efficacy of venetoclax in combination with azacitidine followed by haploidentical transplantation in refractory acute myeloid leukaemia and mixed phenotype acute leukaemia. (3rd April 2020) Authors: Wu, Xiaoxia; Zhang, Jian; Chen, Qiwei; Zhou, Lili; Li, Mengyun; Qiu, Huiying; Sun, Aining; Wu, Depei Journal: British journal of haematology Issue: Volume 189:Number 5(2020) Page Start: e200 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗